ACRO BIOMEDICAL CO., LTD. (ACBM) Operating margin 2017–2022
ACRO BIOMEDICAL CO., LTD. (ACBM) operating margin by fiscal year — reported operating income divided by reported revenue.
-2410.0%FY2022 · since FY2017: -0.4% → -2410.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -2410.0% | -1767.5 pp |
| FY2021 | -642.5% | -623.5 pp |
| FY2020 | -19.0% | +199.5 pp |
| FY2019 | -218.4% | -224.9 pp |
| FY2018 | 6.4% | +6.9 pp |
| FY2017 | -0.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ACBM financial trends
ACBM RevenueACBM Net incomeACBM Net marginACBM Gross profitACBM Gross marginACBM Operating incomeACBM Operating cash flowACBM Free cash flowACBM Capital expendituresACBM Return on equityACBM Stock buybacksACBM Dividends paidACBM Total assetsACBM Total liabilitiesACBM Shareholders’ equityACBM overview →